Latest news with #Lilac


Business Standard
01-07-2025
- Business
- Business Standard
BPL Medical Technologies & Panacea Medical Technologies Announce Strategic Partnership to Offer Advanced Mammography Solutions
India PR Distribution Bengaluru (Karnataka) [India], July 1: BPL Medical Technologies, a pioneer in Indian medical technology, announces a strategic distribution alliance with Panacea Medical Technologies, a trusted name in radiology and cancer care solutions. This partnership allows BPL MedTech to provide advanced mammography solutions under Panacea brand to diagnostic imaging centres, women's health hospitals, and government health institutions across India. With this collaboration, BPL MedTech will now provide both cassette-type and digital mammography systems from the Lilac product line, designed for environments that require high image accuracy, minimal dose exposure and outstanding patient care. The Lilac range offers reliable, efficient, and comfortable breast cancer screening that address the needs of large hospitals, specialized imaging facilities and government institutions. Both cassette-based as well as digital mammography machines feature ergonomic designs and streamlined workflows to improve productivity with patient comfort in mind. Cassette-based systems can be a budget-friendly starting point, which can further be upgraded to digital technology as needed. Digital mammography systems deliver quick, high-resolution output with minimal radiation and seamless compatibility with hospital information systems. This alliance strengthens BPL MedTech's imaging portfolio, empowering healthcare facilities to enhance breast cancer screening and enhance patient outcomes. About BPL Medical Technologies BPL Medical Technologies, a pioneer in Indian medical technology, specializes in the development, manufacturing, and distribution of advanced medical technology across Cardiology, Critical Care & Surgery, Imaging, Mother & Childcare, Home care, and Digital Health Solutions along with Consumables & Accessories. With its registered head office in Bengaluru, two ISO-certified manufacturing facilities in Palakkad and Bengaluru, 14 branch offices, and a nationwide network of over 600 professionals, BPL MedTech is committed to supporting healthcare providers at every level. About Panacea Medical Technologies Founded in India with an aim to improve global access to cancer care by providing high-quality and affordable cancer care equipment to clinicians, Panacea Medical Technologies is dedicated to delivering innovative solutions in radiology and cancer care. Their multidisciplinary team of engineers develop advanced medical equipment that meet international standards, supporting the needs of radiotherapy and radiology centres across the globe. (ADVERTORIAL DISCLAIMER: The above press release has been provided by India PR Distribution. ANI will not be responsible in any way for the content of the same)
Yahoo
24-06-2025
- Business
- Yahoo
ZenToes Gets a Leg up on the Competition with Launch of Premium Compression Socks
BELLINGHAM, Wash., June 24, 2025 /PRNewswire/ -- ZenToes, a leader in effective, affordable and holistic foot care solutions, today announced the launch of its latest innovation, next generation Compression Socks, which are now available at Target, Walmart, on Amazon, and on "At ZenToes, we're committed to making foot care solutions both effective and fun," says ZenToes founder and CEO, Sarah Parks. "With the launch of our Compression Socks, we wanted to make sure that we elevated the typical compression sock experience – creating a product that would offer next level compression and support people in putting their best foot forward every day, so that they could get the most out of life and feel their best doing it. We're thrilled to have achieved that goal with a design that consumers truly love, delivering compression that pays off in comfort and durability at an affordable price." Wearers participating in a recent survey rated the new Compression Socks a step above the competition when it comes to comfort, fit, and ease with three to one preferring ZenToes Compression Socks over a leading premium brand. Priced at $14.99, ZenToes Compression Socks are available in three styles- Basic, Anti-Slip, and Gel Padded- and three colorways–Grey, Blue Frost, and Lilac. Key features and benefits include: Comfort – Cushy, breathable, and designed to go the extra mile (built-in gel cushioning, these are Compression Socks that put comfort first. No digging or slipping, just happy feet. Support – Compression magic that is snug where it counts most to boost circulation and keep the wearer a step ahead. ZenToes Compression Socks feature built-in arch support, anti-slip grippers and a seamless toe. Everyday Relief – Say goodbye to swelling with Compression Socks designed for everyday wear, not just travel. Premium Quality – Materials matter and ZenToes Compression Socks are crafted with the highest quality cotton blend. Built for durability and easy to put on, they're a step above the rest. Designed to promote lasting comfort, ZenToes is delivering everyday support and comfort with moderate 15-20 mmHg compression. The knee high socks are ideal to provide gradual compression and relief from general swelling, during exercise, travel, and extended periods of sitting. For more information about ZenToes and its complete range of foot care solutions, visit For visual assets, please see Dropbox PR Contact:zentoes@ About ZenToesFounded in 2015, ZenToes is an up & coming FDA-registered, podiatrist-recommended foot care brand offering fun and functional products for effective, fast and holistic relief for common foot and ankle conditions. ZenToes products are rigorously tested to provide relief from the discomfort associated with bunions, hammer toes, plantar fasciitis and other common foot conditions. ZenToes is proudly women-owned, WBENC certified and works with Opportunities Inc. to distribute its products with dignity and purpose by individuals with diverse abilities. View original content to download multimedia: SOURCE ZenToes Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

The Age
20-06-2025
- Business
- The Age
‘Melbourne's Silicon Valley' rises as a daytime dining destination. Here are five spots to try
For a suburb often dubbed 'Melbourne's Silicon Valley' because of its melting pot of tech start-ups and creative businesses, Cremorne has never quite had the abundance of hospitality to match such a high-flying crowd. The Cherry Tree is a longstanding boozer, Fred's and Lilac led the area's wine-bar movement, and cafes have long dotted the backstreets. But it wasn't until this year that the inner south-east suburb emerged as a bona fide dining destination. 'A drop in rents post-COVID created really attractive opportunities for hospo operators,' says Stefanie Breschi, director of the new souped-up Japanese convenience store Suupaa. Her eatery neighbours Melbourne's biggest Baker Bleu shop, in the 65 Dover Street development.

Sydney Morning Herald
20-06-2025
- Business
- Sydney Morning Herald
‘Melbourne's Silicon Valley' rises as a daytime dining destination. Here are five spots to try
For a suburb often dubbed 'Melbourne's Silicon Valley' because of its melting pot of tech start-ups and creative businesses, Cremorne has never quite had the abundance of hospitality to match such a high-flying crowd. The Cherry Tree is a longstanding boozer, Fred's and Lilac led the area's wine-bar movement, and cafes have long dotted the backstreets. But it wasn't until this year that the inner south-east suburb emerged as a bona fide dining destination. 'A drop in rents post-COVID created really attractive opportunities for hospo operators,' says Stefanie Breschi, director of the new souped-up Japanese convenience store Suupaa. Her eatery neighbours Melbourne's biggest Baker Bleu shop, in the 65 Dover Street development.


Indian Express
20-06-2025
- Health
- Indian Express
Scientists say they may have found a way to extend human lifespan
For decades, scientists have been trying to find a way to extend human lifespan, and while studies have shown that select lab animals can live longer by eating less, they haven't conducted these studies on humans. A century-old study on lab rats has shown that mice who eat less often outlive their fed counterparts, but it can be almost impossible for most humans to follow a permanent diet. However, a new study by the School of Biological Sciences, University of East Anglia, claims that a combination of FDA-approved drugs that mimic the effects of dieting might be the answer to a longer life. The two drugs – Rapamycin and Metformin are known to extend the lifespan of mice as much as up to 30 per cent. Rapamycin, which was first found in the 1970s in bacteria living on the Easter Island soil, has been traditionally used as a powerful immunosuppressant to prevent organ-transplant rejection. The drug works by disabling a particular switch which is used to inform cells when a cell has an abundance of nutrients. As for Metformin, it is a synthetic compound that is found in French Lilac or Goat's Rue, which doctors prescribe to control sugar levels in type 2 diabetes. Since both of these drugs are used to sense the nutrient and energy levels in the human body, biologists wanted to see if the combination of these drugs could have the same effect as eating less. To know more about their effects, scientists say they examined thousands of existing studies and came across 167 studies that focused on eight vertebrate species, like fish and monkeys, which offered them a detailed insight into how these drugs affected animals. Out of three strategies that help with longevity, eating less, taking Rapamycin and consuming Metformin, scientists say the most dependable way to increase the lifespan is to eat less, irrespective of the animal's sex. They also noted that the second most effective strategy to increase lifespan was to take Rapamycin, while Metformin had no substantial effect. However, scientists did say that the effect of Rapamycin on animals wasn't consistent, as, in some cases, studies have shown that eating less or taking Rapamycin reduced an animal's lifespan. Another thing to note here is that most of these positive effects were on mice and rats, which have genes similar to humans but are not exactly the same. And since Rapamycin does come with some side effects, like reduced immunity, scientists are now trying to see if lower doses of the drug offer some advantages without the side effects. According to an ongoing Rapamycin trial on humans, it was noted that lower doses of the drug might help increase the lifespan. But, as of now, the trial is still in progress and will take a few years before the results are out.